Relationship of HHV-6B Virus to Seizures and Brain Injury
HHV6B in Epilepsy Imaging and CSF Studies
2 other identifiers
observational
33
1 country
1
Brief Summary
This study will look for evidence that a virus called HHV-6B may be related to seizures and to a form of brain injury called mesial temporal sclerosis that is associated with seizures. The study will use new, more sensitive brain scans to try to detect brain regions that might be affected by the virus and will examine cerebrospinal fluid (CSF, the fluid that bathes the brain and spinal cord) for evidence of the virus as well. Healthy volunteers and people with seizures uncontrolled by anti-epileptic drugs who are between 18 and 45 years of age may be eligible for this study. Candidates are screened with a physical examination and laboratory tests. Participants undergo the following procedures:
- PET scan. This test uses a radioactive chemical called 18FDG, which is detected by the PET scanner to obtain images of the brain. The subject lies on a table with his or her head positioned in the scanner. A swimming cap with a small light reflector is placed on the head to monitor the position of the head during the scan. A catheter (plastic tube) is inserted into an artery at the wrist or elbow crease of the arm for obtaining blood samples during the scan, and a second catheter is placed in a vein in the other arm for injecting the 18FDG. The scan takes up to 2 hours. A second scan may be done over an additional 15 minutes.
- MRI. This test uses a strong magnetic field and radio waves to obtain images of the brain. The subject lies on a table that can slide in and out of a metal cylinder surrounded by a magnetic field. Most scans last between 45 and 90 minutes.
- Lumbar puncture. The subject sits upright or lies on a table with the knees curled to the chest for this procedure. A local anesthetic is injected to numb the skin and a needle is inserted in the space between the bones in the lower back where the CSF circulates below the spinal cord. A small amount of fluid is collected through the needle.
- Blood tests. About 4 tablespoons of blood are drawn for viral tests.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 3, 2008
CompletedFirst Submitted
Initial submission to the registry
January 8, 2008
CompletedFirst Posted
Study publicly available on registry
January 18, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2013
CompletedDecember 16, 2019
November 1, 2013
January 8, 2008
December 13, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Detection of evidence for HHV6 infection in CSF
Secondary Outcomes (1)
Detection of lesions on 7T compared to 3T MRI
Eligibility Criteria
You may qualify if:
- Patients will be avaluated for participation under screening protocol 01-N-0139.
- Patients
- Male and female subjects age 18 to 55
- Subjects with seizures uncontrolled by antiepileptic drugs
- Subjects with no other illnesses, or taking other substances or medicines that could interfere with the study
- Healthy Controls
- Male and female subjects age 18 to 55.
You may not qualify if:
- Patient
- Subjects who are pregnant or breast feeding.
- Subjects with any medical condition that could interfere with the study.
- Subjects who are taking drugs that significantly reduce blood clotting such as Coumadin or Warfarin.
- Healthy Volunteers
- Subjects who are pregnant or breast feeding
- Subjects who have any medical condition or be taking any substance or medication that could interfere with the study
- Subjects who are taking drugs that significantly reduce blood cloting such as Coumadin or Warfarin
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
Related Publications (3)
Baker GA, Nashef L, van Hout BA. Current issues in the management of epilepsy: the impact of frequent seizures on cost of illness, quality of life, and mortality. Epilepsia. 1997;38 Suppl 1:S1-8. doi: 10.1111/j.1528-1157.1997.tb04511.x.
PMID: 9092951BACKGROUNDBegley CE, Famulari M, Annegers JF, Lairson DR, Reynolds TF, Coan S, Dubinsky S, Newmark ME, Leibson C, So EL, Rocca WA. The cost of epilepsy in the United States: an estimate from population-based clinical and survey data. Epilepsia. 2000 Mar;41(3):342-51. doi: 10.1111/j.1528-1157.2000.tb00166.x.
PMID: 10714408BACKGROUNDBerg AT, Vickrey BG, Testa FM, Levy SR, Shinnar S, DiMario F, Smith S. How long does it take for epilepsy to become intractable? A prospective investigation. Ann Neurol. 2006 Jul;60(1):73-9. doi: 10.1002/ana.20852.
PMID: 16685695BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
William H Theodore, M.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
Study Record Dates
First Submitted
January 8, 2008
First Posted
January 18, 2008
Study Start
January 3, 2008
Study Completion
November 1, 2013
Last Updated
December 16, 2019
Record last verified: 2013-11-01